Cahyaningsih, Diyah Sukanti ORCID: https://orcid.org/0000-0002-9810-5075 and Candrarin, Grahita (2019) Managerial Efficiency, Innovation and Firm Value of the Pharmaceutical Industry in Indonesia. In: RSU International Research Conference 2019, 26 April 2019, Rangsit University.

Preview	Text 14.LAMPIRAN 7_Managerial Efficiency, Innovation and Firm Value of the Pharmaceutical Industry in.pdf Download (1MB) | Preview
Preview	Text 14. PEER_ managerial_001.pdf Download (961kB) | Preview
Preview	Text 14.TURNITI_Managerial Efficiency, Innovation and Firm Value of the Pharmaceutical Industry in Indonesia_.pdf Download (2MB) | Preview

Abstract

This study examined the effect of managerial efficiency, innovation and firm value. Managerial efficiency is
reflected in optimal input and output management, while the innovation indicator is a comparison of research and
development (R&D) expenditures with sales, while the firm value uses Tobin's Q. The object of this research is 9 out of
10 pharmaceutical companies listed on the Indonesia Stock Exchange, with pooling data during ten years. The results of
this study indicate that, managerial efficiency has a positive effect on innovation and firm value. R&D is the main
activity of the pharmaceutical industry to create patents and exclusive rights in maintaining its market. The more
efficient the manager manages inputs to produce maximum output, the greater investment can be made in the R&D
crowd. The higher the allocation of R&D costs will encourage the number of patents produced, to strengthen companies
in the pharmaceutical market. The higher the level of sales, the greater the profit that can be generated and increase
investor trust

Actions (login required)

View Item